Page 190 - 2019_04-Haematologica-web

P.P. Kulkarni et al.
thrombin-induced platelet aggregation.
Steroids. 2012;77(3):260-268.
31. Lentz BR. Exposure of platelet membrane
phosphatidylserine regulates blood coagula-
tion. Prog Lipid Res. 2003;42(5):423-438.
32. Owens AP, 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res.
2011;108(10):1284-1297.
33. Verhoeven AJ, Mommersteeg ME,
Akkerman JW. Comparative studies on the energetics of platelet responses induced by different agonists. Biochem J. 1986;236(3): 879-887.
34. Akkerman JW, Holmsen H. Interrela- tionships among platelet responses: studies on the burst in proton liberation, lactate pro- duction, and oxygen uptake during platelet aggregation and Ca2+ secretion. Blood. 1981;57(5):956-966.
35. Ravi S, Chacko B, Sawada H, et al. Metabolic plasticity in resting and thrombin activated platelets. PloS one. 2015;10(4): e0123597.
36. Fidler TP, Campbell RA, Funari T, et al. Deletion of GLUT1 and GLUT3 reveals multiple roles for glucose metabolism in platelet and megakaryocyte function. Cell Rep. 2017;20(9):2277.
37. Fidler TP, Middleton EA, Rowley JW, et al. Glucose transporter 3 potentiates degranula- tion and is required for platelet activation. Arterioscler Thromb Vasc Biol. 2017;37(9): 1628-1639.
38. Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol. 2011;43(7):969-980.
39. Lambeth JD, Neish AS. Nox enzymes and new thinking on reactive oxygen: a double- edged sword revisited. Annu Rev Pathol. 2014;9:119-145.
40. Semple JW, Italiano JE Jr., Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011;11(4):264-274.
41. Herter JM, Rossaint J, Zarbock A. Platelets in inflammation and immunity. J Thromb Haemost. 2014;12(11):1764-1775.
42. Dayal S, Wilson KM, Motto DG, Miller FJ, Jr., Chauhan AK, Lentz SR. Hydrogen perox- ide promotes aging-related platelet hyperac- tivation and thrombosis. Circulation. 2013;127(12):1308-1316.
43. Jang JY, Min JH, Chae YH, et al. Reactive oxygen species play a critical role in colla- gen-induced platelet activation via SHP-2 oxidation. Antioxid Redox Signal. 2014;20 (16):2528-2540.
44. Cocco P, Fadda D, Schwartz AG. Subjects expressing the glucose-6-phosphate dehy- drogenase deficient phenotype experience a lower cardiovascular mortality. QJM. 2008;101(2):161-163.
45. Cocco P, Todde P, Fornera S, Manca MB, Manca P, Sias AR. Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency. Blood. 1998;91 (2):706-709.
47. Bersin RM, Stacpoole PW. Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J. 1997;134(5 Pt 1):841-855.
48. Wargovich TJ, MacDonald RG, Hill JA, Feldman RL, Stacpoole PW, Pepine CJ. Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. Am J Cardiol. 1988;61(1):65-70.
49. Deuse T, Hua X, Wang D, et al. Dichloroacetate prevents restenosis in pre- clinical animal models of vessel injury. Nature. 2014;509(7502):641-644.
50. Wu TT, Chen Y, Zhou Y, et al. Prognostic value of dehydroepiandrosterone sulfate for patients with cardiovascular disease: a sys- tematic review and meta-analysis. J Am Heart Assoc. 2017;6(5):e004896.
51. Shirai T, Nazarewicz RR, Wallis BB, et al. The glycolytic enzyme PKM2 bridges meta- bolic and inflammatory dysfunction in coro- nary artery disease. J Exp Med. 2016;213(3): 337-354.
52. Anastasiou D, Yu Y, Israelsen WJ, et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigen- esis. Nat Chem Biol. 2012;8(10):839-847.
53. Dunbar EM, Coats BS, Shroads AL, et al. Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors. Invest New Drugs. 2014;32(3):452-
46. Barak C, Reed MK, Maniscalco SP, Sherry
AD, Malloy CR, Jessen ME. Effects of 464.
dichloroacetate on mechanical recovery and oxidation of physiologic substrates after ischemia and reperfusion in the isolated heart. J Cardiovasc Pharmacol. 1998;31(3): 336-344.
54. Stacpoole PW, Gilbert LR, Neiberger RE, et al. Evaluation of long-term treatment of chil- dren with congenital lactic acidosis with dichloroacetate. Pediatrics. 2008;121(5): e1223-1228.
818
haematologica | 2019; 104(4)